Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy

Antonio Michelucci, Giuseppe Ricciardi, Francesco Sofi, Anna Maria Gori, Francesca Pirolo, Paolo Pieragnoli, Marzia Giaccardi, Andrea Colella, Maria Cristina Porciani, Luigi Di Biase, Luigi Padeletti, Rosanna Abbate, Gian Franco Gensini

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Inflammatory markers are involved in heart failure (HF) pathophysiology. However, the link between these markers and reverse remodeling as well as major adverse cardiac events (HF death, sudden death, and unplanned cardiac rehospitalizations) in patients who undergo cardiac resynchronization therapy (CRT) has not been evaluated. Methods and Results: We recorded major adverse cardiac events of 140 patients (on optimized medical therapy, left ventricular ejection fraction 29.9 ± 9.6%, New York Heart Association Class III-IV, with intraventricular dyssynchrony) who underwent CRT (enrolled since April 2004). Moreover, we evaluated before and after 6 months of CRT: interleukin-6, high-sensitivity C-reactive protein, New York Heart Association class, quality of life (score on Minnesota Living with Heart Failure questionnaire), 6-minute walking test, left ventricular end-diastolic and end-systolic volumes (nonindexed and indexed by body surface area), and left ventricular ejection fraction. Adverse cardiac events were observed in 40 patients (28.6%): 22 deaths and 18 cardiac unplanned rehospitalizations. Only patients without adverse events during follow-up showed a significant reduction of inflammatory markers and left ventricular volumes (reverse remodeling), despite a significant improvement of clinical status observed in both groups of patients. Conclusions: The reduction of inflammatory status seems to be linked to reverse remodeling as well as to a better clinical prognosis in patients with HF who underwent CRT.

Original languageEnglish (US)
Pages (from-to)207-210
Number of pages4
JournalJournal of Cardiac Failure
Volume13
Issue number3
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Cardiac Resynchronization Therapy
Heart Failure
Stroke Volume
Body Surface Area
Sudden Cardiac Death
C-Reactive Protein
Walking
Interleukin-6
Quality of Life

Keywords

  • Adverse cardiac events
  • Cardiac resynchronization therapy
  • Inflammation
  • Remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy. / Michelucci, Antonio; Ricciardi, Giuseppe; Sofi, Francesco; Gori, Anna Maria; Pirolo, Francesca; Pieragnoli, Paolo; Giaccardi, Marzia; Colella, Andrea; Porciani, Maria Cristina; Di Biase, Luigi; Padeletti, Luigi; Abbate, Rosanna; Gensini, Gian Franco.

In: Journal of Cardiac Failure, Vol. 13, No. 3, 04.2007, p. 207-210.

Research output: Contribution to journalArticle

Michelucci, A, Ricciardi, G, Sofi, F, Gori, AM, Pirolo, F, Pieragnoli, P, Giaccardi, M, Colella, A, Porciani, MC, Di Biase, L, Padeletti, L, Abbate, R & Gensini, GF 2007, 'Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy', Journal of Cardiac Failure, vol. 13, no. 3, pp. 207-210. https://doi.org/10.1016/j.cardfail.2006.11.013
Michelucci, Antonio ; Ricciardi, Giuseppe ; Sofi, Francesco ; Gori, Anna Maria ; Pirolo, Francesca ; Pieragnoli, Paolo ; Giaccardi, Marzia ; Colella, Andrea ; Porciani, Maria Cristina ; Di Biase, Luigi ; Padeletti, Luigi ; Abbate, Rosanna ; Gensini, Gian Franco. / Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy. In: Journal of Cardiac Failure. 2007 ; Vol. 13, No. 3. pp. 207-210.
@article{6ec0d6b2a76343fe803cf792065d6dff,
title = "Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy",
abstract = "Background: Inflammatory markers are involved in heart failure (HF) pathophysiology. However, the link between these markers and reverse remodeling as well as major adverse cardiac events (HF death, sudden death, and unplanned cardiac rehospitalizations) in patients who undergo cardiac resynchronization therapy (CRT) has not been evaluated. Methods and Results: We recorded major adverse cardiac events of 140 patients (on optimized medical therapy, left ventricular ejection fraction 29.9 ± 9.6{\%}, New York Heart Association Class III-IV, with intraventricular dyssynchrony) who underwent CRT (enrolled since April 2004). Moreover, we evaluated before and after 6 months of CRT: interleukin-6, high-sensitivity C-reactive protein, New York Heart Association class, quality of life (score on Minnesota Living with Heart Failure questionnaire), 6-minute walking test, left ventricular end-diastolic and end-systolic volumes (nonindexed and indexed by body surface area), and left ventricular ejection fraction. Adverse cardiac events were observed in 40 patients (28.6{\%}): 22 deaths and 18 cardiac unplanned rehospitalizations. Only patients without adverse events during follow-up showed a significant reduction of inflammatory markers and left ventricular volumes (reverse remodeling), despite a significant improvement of clinical status observed in both groups of patients. Conclusions: The reduction of inflammatory status seems to be linked to reverse remodeling as well as to a better clinical prognosis in patients with HF who underwent CRT.",
keywords = "Adverse cardiac events, Cardiac resynchronization therapy, Inflammation, Remodeling",
author = "Antonio Michelucci and Giuseppe Ricciardi and Francesco Sofi and Gori, {Anna Maria} and Francesca Pirolo and Paolo Pieragnoli and Marzia Giaccardi and Andrea Colella and Porciani, {Maria Cristina} and {Di Biase}, Luigi and Luigi Padeletti and Rosanna Abbate and Gensini, {Gian Franco}",
year = "2007",
month = "4",
doi = "10.1016/j.cardfail.2006.11.013",
language = "English (US)",
volume = "13",
pages = "207--210",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Relation of Inflammatory Status to Major Adverse Cardiac Events and Reverse Remodeling in Patients Undergoing Cardiac Resynchronization Therapy

AU - Michelucci, Antonio

AU - Ricciardi, Giuseppe

AU - Sofi, Francesco

AU - Gori, Anna Maria

AU - Pirolo, Francesca

AU - Pieragnoli, Paolo

AU - Giaccardi, Marzia

AU - Colella, Andrea

AU - Porciani, Maria Cristina

AU - Di Biase, Luigi

AU - Padeletti, Luigi

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

PY - 2007/4

Y1 - 2007/4

N2 - Background: Inflammatory markers are involved in heart failure (HF) pathophysiology. However, the link between these markers and reverse remodeling as well as major adverse cardiac events (HF death, sudden death, and unplanned cardiac rehospitalizations) in patients who undergo cardiac resynchronization therapy (CRT) has not been evaluated. Methods and Results: We recorded major adverse cardiac events of 140 patients (on optimized medical therapy, left ventricular ejection fraction 29.9 ± 9.6%, New York Heart Association Class III-IV, with intraventricular dyssynchrony) who underwent CRT (enrolled since April 2004). Moreover, we evaluated before and after 6 months of CRT: interleukin-6, high-sensitivity C-reactive protein, New York Heart Association class, quality of life (score on Minnesota Living with Heart Failure questionnaire), 6-minute walking test, left ventricular end-diastolic and end-systolic volumes (nonindexed and indexed by body surface area), and left ventricular ejection fraction. Adverse cardiac events were observed in 40 patients (28.6%): 22 deaths and 18 cardiac unplanned rehospitalizations. Only patients without adverse events during follow-up showed a significant reduction of inflammatory markers and left ventricular volumes (reverse remodeling), despite a significant improvement of clinical status observed in both groups of patients. Conclusions: The reduction of inflammatory status seems to be linked to reverse remodeling as well as to a better clinical prognosis in patients with HF who underwent CRT.

AB - Background: Inflammatory markers are involved in heart failure (HF) pathophysiology. However, the link between these markers and reverse remodeling as well as major adverse cardiac events (HF death, sudden death, and unplanned cardiac rehospitalizations) in patients who undergo cardiac resynchronization therapy (CRT) has not been evaluated. Methods and Results: We recorded major adverse cardiac events of 140 patients (on optimized medical therapy, left ventricular ejection fraction 29.9 ± 9.6%, New York Heart Association Class III-IV, with intraventricular dyssynchrony) who underwent CRT (enrolled since April 2004). Moreover, we evaluated before and after 6 months of CRT: interleukin-6, high-sensitivity C-reactive protein, New York Heart Association class, quality of life (score on Minnesota Living with Heart Failure questionnaire), 6-minute walking test, left ventricular end-diastolic and end-systolic volumes (nonindexed and indexed by body surface area), and left ventricular ejection fraction. Adverse cardiac events were observed in 40 patients (28.6%): 22 deaths and 18 cardiac unplanned rehospitalizations. Only patients without adverse events during follow-up showed a significant reduction of inflammatory markers and left ventricular volumes (reverse remodeling), despite a significant improvement of clinical status observed in both groups of patients. Conclusions: The reduction of inflammatory status seems to be linked to reverse remodeling as well as to a better clinical prognosis in patients with HF who underwent CRT.

KW - Adverse cardiac events

KW - Cardiac resynchronization therapy

KW - Inflammation

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=34247105726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247105726&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2006.11.013

DO - 10.1016/j.cardfail.2006.11.013

M3 - Article

C2 - 17448418

AN - SCOPUS:34247105726

VL - 13

SP - 207

EP - 210

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 3

ER -